2022
The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas
Hong CS, Omay SB. The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas. Current Oncology 2022, 29: 1408-1421. PMID: 35323318, PMCID: PMC8947636, DOI: 10.3390/curroncol29030118.Peer-Reviewed Original ResearchConceptsSurgical approachBenign primary brain tumorsAggressive surgical resectionAdjuvant radiation therapyOptimal surgical approachInvasive surgical approachPrimary brain tumorsSurgical treatment paradigmMulti-modal managementEloquent neural structuresEndoscopic endonasal approachBenign biologyClinical sequelaeHypothalamic dysfunctionOpen resectionSurgical resectionSignificant morbidityOptic apparatusSafe resectionTumor recurrenceTranscranial surgeryTreatment paradigmDisease entityHypothalamic functionLateral approach
2021
PATH-38. APC MUTATION AS A DRIVER ONCOGENE IN NON-CTNNB1 MUTANT ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
Hong C, Erson-Omay Z, Omay S. PATH-38. APC MUTATION AS A DRIVER ONCOGENE IN NON-CTNNB1 MUTANT ADAMANTINOMATOUS CRANIOPHARYNGIOMAS. Neuro-Oncology 2021, 23: vi123-vi123. PMCID: PMC8598823, DOI: 10.1093/neuonc/noab196.490.Peer-Reviewed Original ResearchAdamantinomatous craniopharyngiomaInstitutional review board-approved protocolCTNNB1 mutationsFamilial adenomatous polyposisWhole-exome sequencingAPC mutationsNeurological deficitsVentricular involvementOptic apparatusClassic subtypeStop codon mutationMalignant tumorsThird ventricleBRAF inhibitorsCraniopharyngeal ductDriver oncogenesTherapeutic strategiesMAP kinase/ERKCraniopharyngiomaGermline APC mutationsPapillary craniopharyngiomasPituitary glandAdenomatous polyposisPathogenic variantsEmbryonic remnants
2019
5 Suprasellar Pathology
Omay S, Anand V, Schwartz T. 5 Suprasellar Pathology. 2019, 61-69. DOI: 10.1007/978-3-319-64379-3_5.Peer-Reviewed Original ResearchSuprasellar lesionsCareful patient selectionVisual field lossEndonasal endoscopic approachEndocrine dysfunctionOptic nerveOptic apparatusPatient selectionSurgical interventionMicroneurosurgical approachesBrain retractionEndoscopic approachPituitary adenomasCarotid arteryEndoscopic methodsThird ventricleEndoscopic techniquesField lossPituitary glandSuprasellar pathologiesLesionsPathologyHydrocephalusTransplanumNerve
2010
SU‐GG‐T‐180: Intensity‐Modulated Radiation Therapy (IMRT) for the Para‐Nasal Sinus (PNS) Malignancies: Outcomes from Fox Chase Cancer Center (FCCC)
Turaka A, Cattaneo R, Nicos N, Lango M, Burtness B, Ridge J, Feigenberg S. SU‐GG‐T‐180: Intensity‐Modulated Radiation Therapy (IMRT) for the Para‐Nasal Sinus (PNS) Malignancies: Outcomes from Fox Chase Cancer Center (FCCC). Medical Physics 2010, 37: 3226-3226. DOI: 10.1118/1.3468570.Peer-Reviewed Original ResearchFox Chase Cancer CenterIntensity-modulated radiation therapySquamous cellsStage III/IV diseaseMedian age 68 yearsStage I/IILocoregional control rateAge 68 yearsOverall survival rateParanasal sinus tumorsBase of skullMedian followMedian doseLocal recurrenceMucosal melanomaSinus malignanciesClinical outcomesDistant metastasisNeck diseasePerineural invasionSinus tumorClinical stageHigher complicationsNegative marginsOptic apparatus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply